Wilfred A. Jefferies
Gründer bei MYND LIFE SCIENCES INC.
Vermögen: 196 471 $ am Heute
Aktive Positionen von Wilfred A. Jefferies
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYND LIFE SCIENCES INC. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | 26.11.2020 | - | |
| Gründer | 06.07.2018 | - | |
| Vorsitzender | 26.11.2020 | 04.12.2023 | |
| University of British Columbia | Corporate Officer/Principal | - | - |
Michael Smith Laboratories
 Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
CAVA Healthcare, Inc.
 CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Vorsitzender | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Eyam Vaccines & Immunotherapeutics Ltd. | Vorsitzender | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Gründer | - | - |
Karriereverlauf von Wilfred A. Jefferies
Ehemalige bekannte Positionen von Wilfred A. Jefferies
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEVIS BRANDS INC. | Gründer | 28.01.2011 | - |
| Corporate Officer/Principal | 28.01.2011 | - | |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Gründer | - | - |
| MARKER THERAPEUTICS, INC. | Vorsitzender | - | 31.08.2009 |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Wilfred A. Jefferies
| University of Victoria | Undergraduate Degree |
| Sir William Dunn School of Pathology | Doctorate Degree |
Statistik
International
| Kanada | 8 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Chairman | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 4 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| MYND LIFE SCIENCES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Commercial Services |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
| Eyam Vaccines & Immunotherapeutics Ltd. |
- Börse
- Insiders
- Wilfred A. Jefferies
- Erfahrung
